Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2008-07-01 / Clin. Cancer Res. 2008 Jul;14(13):4298-305Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
/in Breast Cancer, Dendritic Cells, International Publications /von 2008-06-27 / BMC Immunol. 2008 Jun;9:32Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-8Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2008-05-15 / Clin. Cancer Res. 2008 May;14(10):3098-104Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9Cell- and peptide-based immunotherapeutic approaches for glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-04-09 / Trends Mol Med 2008 May;14(5):228-35Immunotherapy of hematological malignancies using dendritic cells
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2008-03-01 / Bull Cancer 2008 Mar;95(3):320-6Dendritic cell vaccines in melanoma: from promise to proof?
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2008-02-08 / Crit. Rev. Oncol. Hematol. 2008 May;66(2):118-34Immunotherapy opportunities in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2008-02-01 / Expert Rev Anticancer Ther 2008 Feb;8(2):243-57
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de